Page 1 of Clinical Trials for Carmustine, 183 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Terminated
Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.
Last Updated: August 26, 2009
Condition(s): Glioblastoma Multiforme; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma
2
Recruiting
Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)
Last Updated: March 6, 2012
Condition(s): Glioblastoma Multiforme; Gliosarcoma
3
Recruiting
Carmustine, Etoposide, Cytarabine, Melphalan, and Antithymocyte Globulin Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Autoimmune Neurologic Disease That Did Not Respond to Previous Therapy
Last Updated: January 30, 2012
Condition(s): Autoimmune Disorder
4
Recruiting
Gliadel Wafer and Fluorescence-Guided Surgery With Aminolevulinic Acid Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma
Last Updated: April 12, 2012
Condition(s): Brain and Central Nervous System Tumors
5
Recruiting
Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery
Last Updated: September 27, 2011
Condition(s): Brain and Central Nervous System Tumors
6
Recruiting
O6-Benzylguanine and Topical Carmustine in Early-Stage(IA-IIA) Cutaneous T-Cell Lymphoma
Last Updated: February 1, 2012
Condition(s): Lymphoma
7
Terminated
Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant Glioma
Last Updated: October 15, 2009
Condition(s): Brain and Central Nervous System Tumors
8
Active, not recruiting
A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)
Last Updated: September 19, 2011
Condition(s): Malignant Glioma; Glioblastoma Multiforme; Gliosarcoma
9
Active, not recruiting
Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme
Last Updated: October 21, 2009
Condition(s): Brain and Central Nervous System Tumors
10
Completed
Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma
Last Updated: February 6, 2009
Condition(s): Brain and Central Nervous System Tumors
11
Completed
Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma
Last Updated: October 12, 2009
Condition(s): Brain and Central Nervous System Tumors
12
Completed
Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas
Last Updated: December 13, 2011
Condition(s): Brain and Central Nervous System Tumors
13
Completed
O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma
Last Updated: June 9, 2010
Condition(s): Multiple Myeloma and Plasma Cell Neoplasm
14
Recruiting
Surgical Resection With Gliadel Wafer Followed by Dendritic Cells Vaccination for Malignant Glioma Patients
Last Updated: December 18, 2007
Condition(s): Malignant Glioma
15
Completed
Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain Cancer
Last Updated: October 25, 2011
Condition(s): Metastatic Brain Cancer
16
Completed
The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme
Last Updated: June 2, 2011
Condition(s): Glioblastoma Multiforme
17
Recruiting
Dose-Intensive Chemotherapy in Combination With Chemoprotected Autologous Stem Cells for Patients With Malignant Gliomas
Last Updated: May 17, 2012
Condition(s): Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma
18
Completed
O6-Benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma
Last Updated: July 23, 2008
Condition(s): Melanoma (Skin)
19
Active, not recruiting
O6-Benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma
Last Updated: July 23, 2008
Condition(s): Sarcoma
20
Recruiting
Bortezomib and Reduced Intensity Allogenic Stem Cell Transplantation for Lymphoid Malignancies
Last Updated: March 8, 2012
Condition(s): Lymphoma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Carmustine

Page 1 of Clinical Trials for Carmustine, 183 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About